Approval · Notice of Compliance 22577 · 2019
ULTOMIRIS: Notice of Compliance 22577
Issued August 28, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22577
- Date
- August 28, 2019
- Company
- Alexion Pharma GmbhBaar, --, Switzerland
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ULTOMIRIS | 02491559 | Cancelled Post Market |
Medicinal ingredients
- RAVULIZUMAB 10 MG per ML